Granata Bio
granata.bio
Actively hiring
Fertility & IVF
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$23.9M
2 rounds on record
Latest round
$13.8M
Venture round · Dec 2024 · 21 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2024 | $13.8M | — | SEC Form D |
| Venture round | Oct 2023 | $10.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | GRANATA BIO Corp | sec |
Founders and leadersfrom filings, registers and the company's site
Sarah FarandaExecutive Officer, DirectorSEC Form D
Evan SussmanExecutive Officer, DirectorSEC Form D
David PallerExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Overture Life is revolutionizing fertility care with innovative automation technology, making IVF more accessible and affordable worldwide.
Reticular is a reproductive-genetics information service for people planning a pregnancy or using IVF.
Discover automated fertility storage built for IVF clinics and patients. Trusted technology for safe, reliable cryopreservation.
Fertifa is a London health benefits company founded in 2019 that provides reproductive healthcare through employers. Its service covers…
Kindbody is a New York healthcare company founded in 2018 that provides fertility and family-building care. It operates its own clinics and…
Alife is building technology for both clinics and patients.
News
ASRM Spotlight: AMH's Expanding Therapeutic Potential Across Reproductive Medicine
Emerging research shows AMH is more than a marker of ovarian reserve, revealing an addressable therapeutic target with applications across menopause, oncofertility, and IVF stimulation.
Read more
Report
Granata Bio Corporation and Georgetown Equity Partners Announce Joint Venture to Develop a Novel, Next-Generation Form of Follicle-Stimulating Hormone (FSH)
Granata Bio Corporation, a biotechnology company dedicated to advancing fertility and reproductive health, and Georgetown Equity Partners (GEP) today announced the formation of a joint venture to develop hypoglycosylated follicle-stimulating hormone (FSH)
Read more
Report
Granata Bio Corporation and Georgetown Equity Partners Announce Joint Venture to Develop a Novel, Next-Generation Form of Follicle-Stimulating Hormone (FSH)
Read more
Report
Medication madness, increasing involvement of private equity - why IVF costs so much, and how it may get worse - The Boston Globe
The procedure's punishing price tag, even for many with insurance, has led thousands of patients to try money-saving hacks.
Read more
Report
Granata Bio Expands Women
Granata Bio ("Granata") today announced the acquisition of Oviva Therapeutics, Inc. ("Oviva"), a pioneering women
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Sarah Faranda
Executive Officer, Director
Evan Sussman
Executive Officer, Director
David Paller
Executive Officer, Director
Eduardo Hariton
Director
Peter Turek
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Duxbury
United States
HQ
50-200 est. staff
289 Saint George Street Duxbury, MA, 02332 United States